Long radiotherapy course shows better organ preservation in rectal cancer

Cancer News

Long radiotherapy course shows better organ preservation in rectal cancer
RadiotherapyAnal CancerBowel Cancer
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 73 sec. here
  • 16 min. at publisher
  • 📊 Quality Score:
  • News: 78%
  • Publisher: 71%

The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding surgery, preserving the rectum and anus, and preventing regrowth of the primary tumor than a short course of radiotherapy for patients with rectal cancer – a type of bowel cancer.

European Society for Medical Oncology Sep 11 2024 However, the overall survival and survival free of recurrence of the disease remained the same for both treatments.

"The crucial knowledge gaps were whether organ preservation is safe after SCRT and which radiation treatment is best if organ preservation is the goal. Until now, there were no studies comparing SCRT and long course of chemoradiotherapy, LCCRT, in terms of organ preservation and local regrowth rates.

After an average of 31 months, 44.5% of patients receiving LCCRT and 43.4% of patients receiving SCRT had a complete response. After two years, organ preservation was achieved in 40% of LCCRT and 31% of SCRT patients. In patients managed with "watch and wait", LCRT resulted in higher organ preservation at two years and lower local regrowth .

Related Stories "Despite similar clinical complete response rates, we observed more local regrowth after SCRT than LCCRT. This suggests that SCRT may be less durable than LCCRT. If the goal is lifelong organ preservation, LCCRT seems to be the preferred treatment option given our findings of more durable response with LCCRT.

The researchers will continue to monitor the patients to see how they do over a longer term of five to seven years. "I was diagnosed in August of 2022 after having my symptoms dismissed with 'you're too young' and 'you had two natural childbirths, it's probably hemorrhoids' by three GPs who talked to me virtually. I was 46 when I was diagnosed with a 3-4 cm, mid-low, flat rectal tumor," she said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Radiotherapy Anal Cancer Bowel Cancer Chemoradiotherapy Chemotherapy Colorectal Colostomy Covid-19 Lymph Nodes Oncology Pandemic Research Surgery

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Met Office says how long 'autumnal' weather will last ahead of long weekendMet Office says how long 'autumnal' weather will last ahead of long weekendCooler temperatures, wind and rain will feature in the forecast over the coming days, but what will the long weekend look like?
Read more »

Largest study of its kind finds common lab tests aren't reliable for diagnosing long COVIDLargest study of its kind finds common lab tests aren't reliable for diagnosing long COVIDA new study found that most routine laboratory tests are not reliable for diagnosing long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
Read more »

Routine lab tests fail to identify reliable biomarkers for long COVID, study findsRoutine lab tests fail to identify reliable biomarkers for long COVID, study findsStudy found no reliable clinical biomarkers for diagnosing PASC (long COVID) from routine laboratory tests, despite minor differences in some measures between infected and non-infected individuals.
Read more »

Study finds no clinically useful biomarkers for long COVID in routine lab testsStudy finds no clinically useful biomarkers for long COVID in routine lab testsWhether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).
Read more »

Sick days: Assessing the economic costs of long COVIDSick days: Assessing the economic costs of long COVIDA new Yale study finds that the effects of long COVID have caused many Americans to miss extensive work time, and that 14% of study participants reported not returning to work in the months after their infection.
Read more »

Long COVID cost the Australian economy about $9.6 billion in 2022: StudyLong COVID cost the Australian economy about $9.6 billion in 2022: StudyAustralian workers living with long COVID cost the economy, on average, about $9.6 billion in 2022, according to a new study published in the Medical Journal of Australia.
Read more »



Render Time: 2025-02-15 00:44:56